Type
Closure
Country
Romania
Region
Centru; Brasov;
Location of affected unit(s)
Brasov
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

200 jobs
Number of planned job losses
Job loss
Announcement Date
8 February 2016
Employment effect (start)
Foreseen end date
31 March 2016

Description

British Group GlaxoSmithKline (GSK) is to close its local factory Europharm in Brasov in March 2016. As a result 200 employees will lose their job. The  group announced that the redundant employees will receive severance packages and support to find a new job. Some of the production may be transferred to Spain and Poland.

GSK had announced last year its intention to sell the plant due to over-production in the solid oral formulas.

The plant was set up in 1994 and manufactured drugs for the treatment of HIV/AIDS, respiratory disease, depression, the flu/anti-inflammatory. Later in 1996 the British Group acquired 65% stake in the Romanian factory and the remainder 35% in 2003.  


Sources

  • 12 June 2014: România Liberă
  • 29 September 2015: bizbrasov.ro
  • 8 February 2016: Ziarul Financiar

Citation

Eurofound (2016), Europharm, Closure in Romania, factsheet number 86507, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/86507.